119 related articles for article (PubMed ID: 22458349)
1. The association of a distinct plasma proteomic profile with the cervical high-grade squamous intraepithelial lesion of Uyghur women: a 2D liquid-phase chromatography/mass spectrometry study.
Guo X; Abliz G; Reyimu H; Zhao F; Kadeer N; Matsidik R; Wu G; Abudula A
Biomarkers; 2012 Jun; 17(4):352-61. PubMed ID: 22458349
[TBL] [Abstract][Full Text] [Related]
2. [LC-MS/MS-based screening of new protein biomarkers for cervical precancerous lesions and cervical cancer].
Qiu F; Chen F; Liu D; Xu J; He J; Xiao J; Cao L; Huang X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):13-22. PubMed ID: 30692061
[TBL] [Abstract][Full Text] [Related]
3. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
4. A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer.
Boichenko AP; Govorukhina N; Klip HG; van der Zee AG; Güzel C; Luider TM; Bischoff R
J Proteome Res; 2014 Nov; 13(11):4995-5007. PubMed ID: 25232869
[TBL] [Abstract][Full Text] [Related]
5. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.
Vale DB; Westin MC; Zeferino LC
Cancer Cytopathol; 2013 Oct; 121(10):576-81. PubMed ID: 23765869
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
7. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus DNA in plasma of patients with HPV16 DNA-positive uterine cervical cancer.
Shimada T; Yamaguchi N; Nishida N; Yamasaki K; Miura K; Katamine S; Masuzaki H
Jpn J Clin Oncol; 2010 May; 40(5):420-4. PubMed ID: 20133337
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Value of Peripheral Blood Circulating Tumor Cells Detection in Early Cervical Infiltrating Carcinoma Screening].
Chen ZQ; Mi XJ; Liu J; Su NH; Ye CG; Chen A; Duan LF; Dai XZ; Xu XM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):415-419. PubMed ID: 31631610
[TBL] [Abstract][Full Text] [Related]
10. [Study of quantitative detection of circulating DNA in the plasma of patients with cervical lesion].
Wang H; Pan SY; Xu J; Zhang MJ; Chen D; Xia WY; Lu YC; Geng Y; Jin B
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):501-4. PubMed ID: 22041441
[TBL] [Abstract][Full Text] [Related]
11. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women].
Niyazi M; Liu XW; Zhu KC
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):31-4. PubMed ID: 22490852
[TBL] [Abstract][Full Text] [Related]
12. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry.
Gu Y; Wu SL; Meyer JL; Hancock WS; Burg LJ; Linder J; Hanlon DW; Karger BL
J Proteome Res; 2007 Nov; 6(11):4256-68. PubMed ID: 17902640
[TBL] [Abstract][Full Text] [Related]
14. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
15. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
Nasser SM; Cibas ES; Crum CP; Faquin WC
Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
[TBL] [Abstract][Full Text] [Related]
16. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests.
Kahn SL; Ronnett BM; Gravitt PE; Gustafson KS
Cancer; 2008 Feb; 114(1):57-64. PubMed ID: 18181097
[TBL] [Abstract][Full Text] [Related]
17. Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.
Li A; Li J; Austin RM; Wang T; Ashman D; Zhang H; Matsko J; Zhao C
Cancer Cytopathol; 2021 Aug; 129(8):622-631. PubMed ID: 33764649
[TBL] [Abstract][Full Text] [Related]
18. p16INK4a immunohistochemical and histopathologic study of Pap test cases interpreted as HSIL without CIN2-3 identification in subsequent cervical specimens.
Solano FJ; Rush DS; Wilkinson EJ
Int J Gynecol Pathol; 2015 May; 34(3):215-20. PubMed ID: 25844545
[TBL] [Abstract][Full Text] [Related]
19. Possible high-grade squamous intraepithelial lesion (pHSIL) in the new cervical screening paradigm: The outcomes and the role of clinicopathological review.
McGauran MFG; Pendlebury AB; Hiscock RJ; Lamont JM; Jones APM; Grant P; Newman MR; Ireland-Jenkin K; McGrath S; Pham K; Hyde S
Aust N Z J Obstet Gynaecol; 2021 Aug; 61(4):569-575. PubMed ID: 33939180
[TBL] [Abstract][Full Text] [Related]
20. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
